Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$158.56 USD
-2.08 (-1.29%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $158.55 -0.01 (-0.01%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth D Momentum D VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 26% (185 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.24 | 2.10 | 9.99 |
Current Quarter Estimate | 2.33 | 37.64 | 61.00 |
Year Ago Quarter Estimate | 2.66 | 11.39 | 54.84 |
Next Quarter Estimate | 2.35 | 34.85 | 63.00 |
Next Year Estimate | 10.65 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 2.02 | -0.80 | 15.67 |
Next Year | 5.24 | 15.80 | 9.31 |
Last 5 Years | 4.20 | 2.90 | 8.10 |
Next 5 Years | 6.10 | 13.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 15.33 | 15.53 |
Price/Book (MRQ) | 5.41 | 5.91 |
Price/Cash Flow (MRFY) | 11.76 | 11.11 |
Dividend Yield | 3.09% | 2.37% |
Net Profit Margin (TTM) | 46.34% | 40.05% |
Return on Equity (TTM) | 36.60% | 35.68% |
Debt to Equity (MRQ) | 0.44 | 31.94 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.